145038-49-9

Basic information

• Product Name: Fmoc-Glu-OMe
• Synonyms: Fmoc-Glu-OMe;N-α-Fmoc-L-glutamic acid α-methyl ester;(S)-4-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-5-Methoxy-5-oxopentanoic acid;N-Fmoc-L-Glutamic acid 1-methyl ester;(9H-Fluoren-9-yl)MethOxy]Carbonyl Glu-OMe
• CAS NO: 145038-49-9
• Molecular Formula: C₂₁H₂₁NO₆
• Molecular Weight: 383.39454
• Product Categories: Glutamic acid [Glu, E]
• Mol File: 145038-49-9.mol
• Article Data: 0

Chemical Properties

• Melting Point: 139-140 °C
• Boiling Point: 630.6±55.0 °C(Predicted)
• Appearance: /
• Density: 1.296±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 4.46±0.10(Predicted)
• CAS DataBase Reference: Fmoc-Glu-OMe(CAS DataBase Reference)
• NIST Chemistry Reference: Fmoc-Glu-OMe(145038-49-9)
• EPA Substance Registry System: Fmoc-Glu-OMe(145038-49-9)

Safety Data

• Hazardous Substances Data: 145038-49-9(Hazardous Substances Data)

Usage

General Description

Fmoc-Glu-OMe is a chemical compound consisting of the amino acid glutamic acid coupled with a methoxy group and protected with the Fmoc (9-fluorenylmethoxycarbonyl) group. It is often used in the synthesis of peptides and proteins, particularly in solid-phase peptide synthesis. The Fmoc group serves as a temporary protecting group, which can be removed under mild conditions to reveal the free amino group for further chemical reactions. The OMe group provides an additional level of protection for the carboxylic acid group of glutamic acid. Overall, Fmoc-Glu-OMe is an important building block in peptide chemistry for the creation of diverse and complex peptide structures.

Downstream Products

• 443921-91-3 methyl (2S)-4-{4-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-(tert-butoxy)-3-oxopropyl]-1,3-benzoxazol-2-yl}-2-{[(2S)-2-[(tert-butoxycarbonyl)amino]-6-phthalimidohexanoyl]amino}butanoate 
• 443921-90-2 methyl (2S)-4-{4-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-(tert-butoxy)-3-oxopropyl]-1,3-benzoxazol-2-yl}-2-{[(2S)-2-[(tert-butoxycarbonyl)amino]-3-(benzyloxycarbonyl)propanoyl]amino}butanoate 
• 443922-00-7 methyl (7S,10S,13S)-10-(4-phthalimidobutyl)-7-{[(benzyloxy)carbonyl]amino}-8,11-dioxo-19-oxa-9,12,17-triazatricyclo[14.2.1.0^6,18]nonadeca-1⁽¹⁸⁾,2,4,16-tetraene-13-carboxylate 
• 443921-89-9 methyl (2S)-4-{4-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-(tert-butoxy)-3-oxopropyl]-1,3-benzoxazol-2-yl}-2-{[(2S)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropanoyl]amino}butanoate 
• 443921-80-0 methyl (2S)-4-{4-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-(tert-butoxy)-3-oxopropyl]-1,3-benzoxazol-2-yl}-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}butanoate 
• 443921-99-1 methyl (7S,10S,13S)-10-(benzyloxycarbonylmethyl)-7-{[(benzyloxy)carbonyl]amino}-8,11-dioxo-19-oxa-9,12,17-triazatricyclo[14.2.1.0^6,18]nonadeca-1⁽¹⁸⁾,2,4,16-tetraene-13-carboxylate 
• 443921-98-0 methyl (7S,10S,13S)-10-benzyl-7-{[(benzyloxy)carbonyl]amino}-8,11-dioxo-19-oxa-9,12,17-triazatricyclo[14.2.1.0^6,18]nonadeca-1⁽¹⁸⁾,2,4,16-tetraene-13-carboxylate 
• 443922-01-8 methyl (7S,10S,13S)-7-acetylamino-10-benzyl-8,11-dioxo-19-oxa-9,12,17-triazatricyclo[14.2.1.0^6,18]nonadeca-1⁽¹⁸⁾,2,4,16-tetraene-13-carboxylate 
• 157-03-9 6-diazo-5-oxo-L-norleucine